Skip to main content
. 2005 Aug 25;7(5):R862–R870. doi: 10.1186/bcr1313

Table 3.

Relationship between COX-2 and MDR1/P-gp (detected with C219 or JSB-1 antibodies) expression (Chi2-Test, P < 0.001)

COX-2 positive cases COX-2 negative cases Sum
Entire study group (n = 104)
 C219 low [IRS 0–3] 56 5 61
 C219 high [IRS 4–12] 2 41 43
  Sum 58 46 104
 JSB-1 low [IRS 0–3] 55 4 59
 JSB-1 high [IRS 4–12] 3 42 45
  Sum 58 46 104
Patients postoperatively treated only with chemotherapy (n = 28)
 C219 low [IRS 0–3] 13 1 14
 C219 high [IRS 4–12] 1 13 14
  Sum 14 14 28
 JSB-1 low [IRS 0–3] 12 1 13
 JSB-1 high [IRS 4–12] 2 13 15
  Sum 14 14 28

COX-2, cyclooxygenase-2; MDR1/P-gp, MDR1/P-glycoprotein; IRS, immunoreactive score [17].